HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spyros P Nikas Selected Research

methanandamide

10/2021Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression.
10/2018( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Spyros P Nikas Research Topics

Disease

4Pain (Aches)
01/2019 - 07/2005
4Hypothermia
08/2015 - 03/2012
2Respiratory Insufficiency (Respiratory Failure)
10/2022 - 10/2021
2Tremor (Tremors)
01/2022 - 01/2022
1Sleep Deprivation
01/2022
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2020
1Vomiting
01/2020
1Sialorrhea
01/2020
1Hyperalgesia
01/2019
1Neuralgia (Stump Neuralgia)
01/2019
1Seizures (Absence Seizure)
09/2017
1Catalepsy
08/2015
1Insulin Resistance
11/2010
1Hypertension (High Blood Pressure)
11/2010
1Hyperglycemia
11/2010
1Glaucoma
07/2005
1Multiple Sclerosis
07/2005

Drug/Important Bio-Agent (IBA)

5CannabinoidsIBA
10/2022 - 01/2013
53- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA
01/2022 - 03/2012
3Morphine (MS Contin)FDA LinkGeneric
10/2022 - 01/2019
2Opioid Analgesics (Opioids)IBA
10/2022 - 10/2021
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2022 - 07/2005
2methanandamideIBA
10/2021 - 10/2018
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2021 - 01/2019
2Pharmaceutical PreparationsIBA
12/2017 - 03/2012
2Dronabinol (THC)FDA LinkGeneric
08/2015 - 12/2012
1morpholineIBA
10/2022
1PrNMIIBA
10/2022
1NicotineFDA Link
01/2020
1AntiemeticsIBA
01/2020
1Lithium ChlorideIBA
01/2020
13- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA
01/2019
1Gabapentin (Neurontin)FDA LinkGeneric
01/2019
1Freund's AdjuvantIBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
01/2019
1Analgesics (Analgesic Drugs)IBA
10/2018
1EndocannabinoidsIBA
12/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
09/2017
1Paraoxon (E600)IBA
09/2017
1Nerve AgentsIBA
09/2017
1Cholinesterase Inhibitors (Anticholinesterases)IBA
09/2017
1Mesylates (Mesylate)IBA
01/2013
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2013
19- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA
01/2013
1AM 251 (AM251)IBA
03/2012
1LigandsIBA
03/2012
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
11/2010
1AM 3506IBA
11/2010

Therapy/Procedure

3Analgesia
10/2021 - 01/2013
2Therapeutics
10/2022 - 10/2021
2Drug Therapy (Chemotherapy)
01/2020 - 01/2019
1Ligation
01/2019